Sunlight Reduces Diabetes and Metabolic Syndrome Risk, Studies Show

Part 4 of the series: Beyond Vitamin D: The Hidden Lifesaving Benefits of Sunlight

🎧 ▶️ Press the play button below to listen.

Introduction

Type 2 diabetes and metabolic syndrome are global epidemics.

Together, they affect over a billion people. They are not merely diseases of sugar. They are diseases of the entire metabolic system — the liver, the pancreas, the blood vessels, the adipose tissue, and the brain.

They shorten lives not just through heart attacks and strokes, but through kidney failure, blindness, amputations, dementia, and cancer.

The standard advice is familiar: eat less, move more, take your medication. It is good advice. It is also insufficient. The epidemic grows.

Now consider a question that, once again, sounds improbable: Could a beam of light help control blood sugar?

Could sunlight — the same sunlight we know triggers nitric oxide release and lowers blood pressure — also influence how the body handles glucose?

The evidence says yes. And once again, it is not about vitamin D.

In the first two articles of this series, we examined how sunlight exposure was associated with longer life in Swedish women and how UVA-driven nitric oxide release directly lowers blood pressure and cardiovascular mortality. The heart, we learned, is protected by a mechanism unrelated to the “sunshine vitamin.”

The metabolic system is the next target. The evidence is younger than the cardiovascular literature, but it is growing fast — and it points toward a sunlight-metabolism connection that operates through multiple independent pathways.


Why Metabolic Syndrome Matters Beyond Diabetes

Before diving into the studies, it is worth pausing on what metabolic syndrome actually is and why it matters so much.

Metabolic syndrome is not a single disease. It is a cluster of interconnected disorders that tend to travel together:

  • Abdominal obesity — excess fat around the organs
  • Insulin resistance — cells stop responding to insulin, forcing the pancreas to overwork
  • High blood pressure — which we already know sunlight helps lower
  • High blood triglycerides — fats circulating in the blood
  • Low HDL cholesterol — the protective lipoprotein

A person with metabolic syndrome has a substantially increased risk of developing:

  • Type 2 diabetes — the endpoint of pancreatic beta-cell exhaustion
  • Cardiovascular disease — heart attacks, strokes, and peripheral artery disease
  • Non-alcoholic fatty liver disease (NAFLD) — now the leading cause of liver transplants
  • Polycystic ovary syndrome (PCOS) — a leading cause of infertility
  • Certain cancers — including colon, breast, and liver
  • Dementia and Alzheimer’s disease — now sometimes called “type 3 diabetes.”

Metabolic syndrome is not just about blood sugar. It is a systemic failure of energy regulation that accelerates aging across all organs. If sunlight can reduce its prevalence — even modestly — the implications are enormous.

Below is a list of articles I wrote about the disease conditions associated with metabolic syndrome.


The Mouse Study: UVR Suppresses Obesity Without Vitamin D

The landmark study that opened this field was published in 2014 in the journal Diabetes by researchers at the Telethon Kids Institute in Australia. [1]

The design was simple and powerful.

They took mice fed a high-fat diet — a standard model for inducing obesity and insulin resistance, the precursors to type 2 diabetes — and divided them into three groups:

  • Group 1: Exposed to low-dose ultraviolet radiation (UVR) on their shaved backs, mimicking moderate sun exposure.
  • Group 2: Given oral vitamin D supplementation at doses sufficient to raise blood levels significantly.
  • Group 3: Controls — high-fat diet, no UVR, no vitamin D.

If vitamin D were the mechanism by which sunlight affected metabolism, Groups 1 and 2 should have looked similar. They did not.

The UVR-exposed mice gained significantly less weight on the same high-fat diet. They showed fewer signs of insulin resistance. Their metabolic profiles were healthier.

The vitamin D-supplemented mice showed no such benefit. Their weight gain, insulin sensitivity, and metabolic markers were no different from those of the controls.

The researchers concluded that UVR was suppressing obesity and the metabolic consequences of a poor diet through a mechanism completely independent of vitamin D.

When they analyzed the skin of the UVR-exposed mice, they found elevated levels of nitric oxide metabolites. The proposed mechanism was, once again, nitric oxide release from the skin — the same pathway that lowers blood pressure in humans.

Nitric oxide, it turns out, does more than dilate blood vessels. It also plays a role in:

  • Glucose uptake by skeletal muscle — the primary site where the body clears sugar from the blood
  • Mitochondrial function — the energy factories of cells, whose dysfunction is central to insulin resistance
  • Inflammation reduction — chronic low-grade inflammation is a driver of metabolic disease

A mouse study cannot prove the same mechanism operates identically in humans. But it provided a proof of principle: sun exposure on skin, not vitamin D in a pill, protected against diet-induced metabolic disease.


The Human Evidence: Gestational Diabetes and First-Trimester Sun Exposure

The next question was whether this effect was visible in humans. A 2022 study published in the Journal of Clinical Endocrinology & Metabolism provided a compelling answer. [2]

Researchers used data from a large U.S. pregnancy cohort and linked each participant’s residential location to satellite-measured solar irradiance during pregnancy. They examined the association between sun exposure in the first trimester and the subsequent development of gestational diabetes mellitus (GDM) — a form of diabetes that appears during pregnancy and identifies women at high risk for later type 2 diabetes.

The findings were striking:

  • Women with the highest first-trimester sun exposure had a significantly lower risk of developing gestational diabetes.
  • The protective effect was independent of vitamin D status, ambient temperature, physical activity, and BMI.
  • The first trimester appeared to be a critical window — when the placenta is developing and maternal metabolic adaptations are being established.

Gestational diabetes is not a trivial condition. It affects up to 10% of pregnancies. It increases the risk of complications during delivery, macrosomia (excessively large babies), and neonatal hypoglycemia. Women who develop GDM have a sevenfold increased risk of developing type 2 diabetes later in life. Their children are also at higher risk of obesity and metabolic disease.

That sunlight exposure during the first trimester — a completely modifiable factor — was independently associated with lower GDM risk is a finding with significant public health implications. It suggests that advising pregnant women to avoid the sun may be depriving them of a metabolic benefit during a critical developmental window.


The 2024 German Cohort Study: UVR and Metabolic Syndrome Prevalence

The most recent and arguably most important piece of human evidence comes from a 2024 study published in the Journal of Investigative Dermatology. [3]

German researchers used data from a large national cohort and linked each participant’s residential address to satellite-measured solar UVR exposure. They then examined the association between UVR and the prevalence of metabolic syndrome — the cluster of conditions described earlier.

The results were clear and dose-dependent:

  • Increased solar UVR exposure was associated with a linear decrease in the prevalence of metabolic syndrome.
  • The more UVR people were exposed to in their homes, the less likely they were to have the syndrome.
  • This association was independent of vitamin D levels and of physical activity.
  • The effect was consistent across different subgroups of the population.

A linear dose-response relationship is one of the strongest indicators of a genuine causal association in epidemiology. It is difficult to explain away by confounding.

The German study represents the best human evidence to date that the sunlight-metabolism connection observed in mice translates to real-world human populations. People living in sunnier areas, or with more UVR exposure, simply have healthier metabolic profiles — and this cannot be attributed to vitamin D status or differences in exercise.

ALT_TEXT - Infographic summarizing three key studies on sunlight and metabolic health. Mouse study 2014: UVR suppressed obesity and insulin resistance on high-fat diet, vitamin D group showed no benefit. Human study 2022: higher first-trimester sun exposure lowered gestational diabetes risk, independent of vitamin D. German cohort 2024: satellite-measured UVR linked to linear decrease in metabolic syndrome prevalence, independent of vitamin D and physical activity.
The evidence linking sunlight to metabolic health spans animal models and human populations. Each study found benefits independent of vitamin D. References: Geldenhuys et al., 2014; Liu et al., 2022; Schrempft et al., 2024.

The Missing Piece: Direct Mortality Data

The cardiovascular literature has multiple studies showing lower CVD mortality with higher sun exposure. The metabolic literature, at present, has more evidence on incidence and prevalence than on direct mortality from diabetes or metabolic syndrome.

This is partly because metabolic deaths are harder to isolate. When a person with diabetes dies of a heart attack, the death is coded as cardiovascular. When they die of kidney failure, it is coded as renal. Diabetes is often the underlying driver but not the stated cause on a death certificate.

However, the existing evidence is strongly suggestive:

  • The Swedish study we opened this series with found that sun avoiders had higher non-cancer, non-CVD mortality — a broad category that includes deaths from diabetes, infections, and other metabolic-related conditions. [4]
  • The U.S. NIH-AARP study found that higher UVR exposure was associated with lower all-cause mortality, with contributions from multiple cause-specific categories. [5]
  • The Danish nationwide study found that a history of non-melanoma skin cancer — a sun exposure marker — was associated with lower all-cause mortality, which inherently includes metabolic deaths. [6]

There is not yet a large prospective study titled “Sun Exposure and Diabetes Mortality.” But the existing all-cause mortality data, combined with the incidence and prevalence studies in mice and humans, strongly suggest that the metabolic benefits of sunlight are real and translate into longer life.

This is an area where the literature is still maturing. The German 2024 study is the strongest evidence yet, and it is likely that mortality-specific analyses will follow.


The Mechanisms: How Sunlight Influences Metabolism

The mouse study pointed to nitric oxide. The human studies show effects independent of vitamin D and physical activity. What are the actual biological pathways through which sunlight could influence glucose metabolism and metabolic health?

Mechanism 1: Nitric Oxide and Glucose Uptake

Nitric oxide, the same molecule released from skin by UVA and blue light, plays a well-documented role in glucose metabolism:

  • In skeletal muscle, nitric oxide stimulates glucose uptake independently of insulin. It activates the GLUT4 glucose transporter through a pathway parallel to insulin signaling.
  • In blood vessels, nitric oxide improves microvascular blood flow, enhancing the delivery of glucose and insulin to muscle tissue.
  • In the liver, nitric oxide modulates hepatic glucose production, helping prevent the excessive glucose output that characterizes type 2 diabetes.

A person with regular sun exposure is getting regular, pulsatile doses of nitric oxide. A person who avoids the sun is not. Over the years, this difference in NO availability could meaningfully affect insulin sensitivity and glucose handling.

Mechanism 2: Circadian Rhythms and Insulin Sensitivity

This is a mechanism that operates through the eyes, not the skin.

The suprachiasmatic nucleus (SCN) in the brain is the body’s master clock. It is set primarily by blue and green light entering the eyes during the day, particularly in the morning. A robust light-dark signal synchronizes every peripheral clock in the body — including those in the liver, pancreas, muscle, and adipose tissue.

When these clocks are synchronized:

  • Insulin sensitivity is highest in the morning, when the body expects food and activity.
  • Pancreatic beta-cells secrete insulin in a coordinated, efficient rhythm.
  • Adipose tissue properly stores and releases fat according to the feeding-fasting cycle.

When the circadian system is disrupted — by insufficient daytime light, excessive nighttime light, shift work, or irregular sleep — the metabolic consequences are profound:

  • Insulin resistance develops.
  • Beta-cell function deteriorates.
  • Postprandial (after-meal) blood sugar spikes become larger and prolonged.
  • The risk of metabolic syndrome and type 2 diabetes rises.

A sun-avoiding person who spends their days in dim indoor light and their evenings in bright artificial light is, from a circadian perspective, in a state of chronic jet lag. Their metabolic clocks are misaligned. Morning sunlight, through the eyes, is the most powerful signal to reset them.

Mechanism 3: Infrared and Near-Infrared Light — The Mitochondrial Connection

There is a third mechanism that operates at wavelengths most people do not associate with health effects at all.

Infrared (IR) and near-infrared (NIR) light make up roughly half of the solar energy that reaches the Earth’s surface. They are felt as warmth on the skin, but they do much more than heat. They penetrate deeply into tissues — NIR can reach several centimeters beneath the skin — and they are absorbed by an enzyme buried inside our cells: cytochrome c oxidase.

Cytochrome c oxidase is the final enzyme in the mitochondrial electron transport chain. It is the rate-limiting step for ATP production — the fundamental energy currency of every cell. When NIR photons are absorbed by this enzyme, they displace inhibitory nitric oxide molecules, allowing the enzyme to function more efficiently. The result is:

  • Increased ATP production — more cellular energy
  • Reduced oxidative stress — less damaging reactive oxygen species leaking from mitochondria
  • Improved mitochondrial function — the core defect in many metabolic disorders

Why does this matter for metabolism?

Mitochondrial dysfunction is now recognized as a central driver of insulin resistance and type 2 diabetes. Skeletal muscle mitochondria in insulin-resistant individuals are less efficient at oxidizing fatty acids. This leads to the accumulation of lipid intermediates that interfere with insulin signaling. The pancreas, liver, and adipose tissue are similarly affected.

By improving mitochondrial efficiency, NIR light may directly address this underlying pathology.

The Evidence for NIR and Metabolism

The evidence comes from multiple sources:

  • Animal studies: Mice with diet-induced obesity exposed to NIR light show improved glucose tolerance, reduced fat accumulation, and lower inflammation — independently of any effect on vitamin D or nitric oxide.
  • Human photobiomodulation trials: Low-level light therapy using red and NIR wavelengths has been shown to improve muscle performance, reduce muscle fatigue, and enhance post-exercise recovery. Some studies report modest but measurable improvements in insulin sensitivity.
  • Mechanistic studies: NIR has been shown to reduce inflammation by downregulating NF-kB, a master inflammatory transcription factor that is chronically activated in obesity and metabolic syndrome. It also improves microvascular blood flow, aiding nutrient and oxygen delivery to tissues.

The Environmental Context

This mechanism may help explain a paradox within the larger sunlight paradox. Modern humans spend 90% of their time indoors, behind glass that blocks UVB completely and UVA partially. But it also blocks a significant portion of NIR. LED and fluorescent lighting emit effectively zero NIR. Incandescent bulbs, which do emit NIR, have been largely phased out.

We have not only removed UV-mediated vitamin D and nitric oxide from our lives. We have removed the infrared component of sunlight that our mitochondria evolved to expect. It is a triple deficiency.

The Practical Implication

Morning sunlight, rich in infrared and NIR, may be particularly beneficial. It delivers the circadian-setting blue light through the eyes, the nitric-oxide-releasing UVA to the skin, and the mitochondrial-stimulating NIR to deep tissues — all in a single exposure that no indoor environment or supplement can replicate.

This also reinforces a point made throughout this series: the sun’s benefits are not interchangeable with any single pill or device. They are the product of a full-spectrum physiological stimulus that our bodies evolved in response to over millions of years.

A complete list of the effects of infrared and near-infrared light on health is available in the related articles below.

ALT_TEXT -  Infographic showing three independent pathways by which sunlight improves metabolic health. Pathway 1: UVA and blue light trigger nitric oxide release from skin, improving glucose uptake in muscle. Pathway 2: Blue and green light through eyes synchronize circadian clock, improving insulin sensitivity. Pathway 3: Infrared and near-infrared light penetrate deep tissues, improving mitochondrial function and ATP production. All pathways are independent of vitamin D.
Sunlight improves metabolic health through three independent pathways — nitric oxide, circadian entrainment, and mitochondrial enhancement. A vitamin D pill provides none of them. Adapted from Geldenhuys et al., Diabetes, 2014; Schrempft et al., JID, 2024.

Mechanism 4: Vitamin D and Pancreatic Function

While the mouse and German studies showed effects independent of vitamin D, this does not mean vitamin D is irrelevant to metabolism. It plays a supporting role:

  • Pancreatic beta-cells express vitamin D receptors.
  • Vitamin D is required for normal insulin secretion.
  • Severe vitamin D deficiency impairs glucose tolerance.

But the evidence suggests that vitamin D is permissive rather than primary. You need enough for normal function, but beyond sufficiency, more vitamin D does not linearly improve metabolic health. The larger metabolic effects of sunlight appear to be driven by nitric oxide and circadian entrainment — mechanisms that vitamin D cannot replicate.


The Synergy: Sunlight, Metabolism, and Cardiovascular Health

The metabolic and cardiovascular benefits of sunlight are not separate stories. They are deeply interconnected.

  • Nitric oxide simultaneously lowers blood pressure and improves glucose uptake.
  • Circadian entrainment simultaneously improves insulin sensitivity and regulates the timing of blood pressure dips.
  • Reduced inflammation from both pathways benefits the endothelium, the liver, and the adipose tissue.

A person who gets regular, moderate sun exposure is receiving a daily metabolic and cardiovascular tune-up through multiple independent mechanisms. A person who avoids the sun is deficient in all of them.

This may explain why the Swedish women who avoided the sun had such a pronounced mortality disadvantage. They were not missing just one protective factor. They were missing an entire suite of them, operating in concert.


Key Takeaways

  • Metabolic syndrome is a cluster of disorders — obesity, insulin resistance, hypertension, dyslipidemia — that increases the risk of diabetes, cardiovascular disease, liver disease, dementia, and cancer.
  • A mouse study proved UVR suppresses obesity and insulin resistance on a high-fat diet, independently of vitamin D. Vitamin D-supplemented mice showed no benefit. The mechanism: nitric oxide.
  • Gestational diabetes risk was lower in women with higher first-trimester sun exposure, independent of vitamin D, temperature, and physical activity. A critical window for maternal-fetal metabolic health.
  • A 2024 German study linked satellite-measured UVR exposure to a linear decrease in metabolic syndrome prevalence, independent of vitamin D and exercise.
  • Direct mortality data for metabolic deaths alone is still developing, but all-cause mortality studies consistently show lower death rates in sun-exposed groups.
  • Three mechanisms explain the sunlight-metabolism connection: Nitric oxide improves glucose uptake in muscle; circadian light signals through the eyes synchronize metabolic clocks; vitamin D plays a permissive role in insulin secretion.
  • Sunlight’s cardiovascular and metabolic benefits overlap and reinforce each other — nitric oxide and circadian entrainment serve both systems simultaneously.
  • Sunlight is not a substitute for diet and exercise — but it may be an underappreciated third pillar of metabolic health, and one we have inadvertently removed from modern life.

Looking Ahead

If sunlight protects the heart and improves metabolic health, what about cancer?

This is where the paradox deepens. The sun causes skin cancer — we established that in Article 1. But it may also protect against some of the most common and lethal internal cancers. Colon cancer. Breast cancer. Prostate cancer. Lymphoma.

The mechanisms shift again. For these cancers, vitamin D re-enters the picture, alongside direct immune modulation by ultraviolet radiation on the skin.

The next article will explore the evidence that the sun is not just a skin carcinogen — it may be a systemic cancer preventive, and the balance of risk and benefit may surprise you.

Don’t Get Sick!

About Dr. Jesse Santiano, MD

Dr. Santiano is a retired internist and emergency physician with extensive clinical experience in metabolic health, cardiovascular prevention, and lifestyle medicine. He reviews all medical content on this site to ensure accuracy, clarity, and safe application for readers. This article is for educational purposes and is not a substitute for personal medical care.

💡 Support This Work

Creating well-researched articles, maintaining this website, and keeping the information free takes time and resources.
If you found this article helpful, please consider donating to support the mission of empowering people to live healthier, longer lives, without relying on medications.

🙏 Every contribution, big or small, truly makes a difference. Thank you for your support!

Follow me on FacebookGabTwitter (formerly known as X), Instagram, and Telegram.

Related:

References:

[1] Geldenhuys S, Hart PH, Endersby R, et al. Ultraviolet radiation suppresses obesity and symptoms of the metabolic syndrome independently of vitamin D in mice fed a high-fat diet. Diabetes. 2014;63(11):3759-3769. doi:10.2337/db14-0473

[2] Liu X, Ji J, Chen T, et al. Association of sun exposure and gestational diabetes mellitus in the United States. Journal of Clinical Endocrinology & Metabolism. 2022;107(7):e2841-e2849. doi:10.1210/clinem/dgac217

[3] Schrempft S, Cesarini D, et al. Solar ultraviolet radiation exposure is associated with a lower prevalence of metabolic syndrome. Journal of Investigative Dermatology. 2024;144(5):1157-1164.e2. doi:10.1016/j.jid.2023.10.024

[4] Lindqvist PG, Epstein E, Landin-Olsson M, et al. Avoidance of sun exposure as a risk factor for major causes of death: a competing risk analysis of the Melanoma in Southern Sweden cohort. Journal of Internal Medicine. 2014;276(1):77-86. doi:10.1111/joim.12296

[5] Lin SW, Wheeler DC, Park Y, et al. Prospective study of ultraviolet radiation exposure and mortality risk in the United States. American Journal of Epidemiology. 2013;178(4):521-529. doi:10.1093/aje/kws589

[6] Brøndum-Jacobsen P, Nordestgaard BG, Nielsen SF, Benn M. Skin cancer as a marker of sun exposure associates with lower risk of myocardial infarction, hip fracture, and all-cause mortality. International Journal of Epidemiology. 2019;48(4):1096-1107. doi:10.1093/ije/dyz038

Disclaimer:
This article is for educational purposes and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician before making health decisions based on the TyG Index or other biomarkers.

© 2018 – 2026 Asclepiades Medicine, LLC. All Rights Reserved
DrJesseSantiano.com does not provide medical advice, diagnosis, or treatment


Discover more from Don't Get Sick!

Subscribe to get the latest posts sent to your email.

Let me know what you think!